Press Releases

July 1, 2020

ProterixBio licenses COVID-19 serology test from Massachusetts General Hospital

Billerica, MA, July 1, 2020: ProterixBio, Inc. today announced completing a licensing agreement with the Massachusetts General Hospital for a COVID-19 serology assay. The assay was developed and validated by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University which is a joint venture of Harvard University, Massachusetts… Read more »

May 21, 2018

ProterixBio Presents Results from Multiple COPD Clinical Studies at the American Thoracic Society International Conference

Billerica MA, May 22, 2018 – ProterixBio, Inc. today announced that results from three clinical studies of subjects with chronic obstructive pulmonary disease (COPD) were presented at the American Thoracic Society International Conference this week. One presentation, “Prospective Evaluation of Algorithms Based on Blood Biomarkers as Guides for COPD Assessment and Risk Stratification,” highlighted that… Read more »

September 11, 2017

ProterixBio presents COPD clinical study results at the European Respiratory Society International Congress

Billerica MA, September 12, 2017 – ProterixBio, Inc. today announced that results from a recent clinical study of subjects with chronic obstructive pulmonary disease (COPD) were presented this week at the European Respiratory Society International Congress. Algorithms based on combinations of protein biomarkers were successfully associated with measures of COPD disease activity such as shortness… Read more »